CareDx ROE 2013-2024 | CDNA

Current and historical return on equity (ROE) values for CareDx (CDNA) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
CareDx ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-03-31 $-0.18B $0.26B -55.62%
2023-12-31 $-0.19B $0.26B -51.35%
2023-09-30 $-0.09B $0.39B -21.82%
2023-06-30 $-0.08B $0.41B -19.85%
2023-03-31 $-0.08B $0.42B -18.71%
2022-12-31 $-0.08B $0.43B -17.40%
2022-09-30 $-0.08B $0.44B -16.62%
2022-06-30 $-0.07B $0.44B -15.22%
2022-03-31 $-0.05B $0.46B -10.66%
2021-12-31 $-0.03B $0.47B -6.56%
2021-09-30 $-0.02B $0.47B -4.47%
2021-06-30 $-0.01B $0.48B -2.67%
2021-03-31 $-0.02B $0.47B -4.69%
2020-12-31 $-0.02B $0.28B -8.80%
2020-09-30 $-0.02B $0.27B -11.51%
2020-06-30 $-0.02B $0.26B -14.31%
2020-03-31 $-0.02B $0.10B -21.48%
2019-12-31 $-0.02B $0.10B -23.83%
2019-09-30 $-0.02B $0.10B -22.98%
2019-06-30 $-0.04B $0.09B -48.63%
2019-03-31 $-0.05B $0.10B -69.43%
2018-12-31 $-0.05B $0.10B -93.07%
2018-09-30 $-0.08B $0.04B -300.00%
2018-06-30 $-0.07B $0.03B -492.86%
2018-03-31 $-0.06B $0.03B -605.13%
2017-12-31 $-0.06B $-0.01B -1066.67%
2017-09-30 $-0.04B $0.00B -331.91%
2017-06-30 $-0.03B $0.01B -138.10%
2017-03-31 $-0.04B $0.02B -133.33%
2016-12-31 $-0.04B $0.02B -141.82%
2016-09-30 $-0.03B $0.04B -97.48%
2016-06-30 $-0.03B $0.03B -96.55%
2016-03-31 $-0.02B $0.02B -70.00%
2015-12-31 $-0.01B $0.03B -37.41%
2015-09-30 $-0.01B $0.03B -21.19%
2015-06-30 $-0.00B $0.04B -10.13%
2015-03-31 $0.00B $0.04B 0.00%
2014-12-31 $0.00B $0.04B 6.25%
2014-09-30 $0.00B $0.04B 0.00%
2014-06-30 $-0.00B $-0.00B 24.24%
2014-03-31 $-0.00B $-0.02B 50.00%
2013-12-31 $-0.00B $-0.02B 106.67%
Sector Industry Market Cap Revenue
Medical Medical Services $0.942B $0.280B
CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $115.971B 14.14
Cencora (COR) United States $44.597B 17.39
ICON (ICLR) Ireland $27.199B 25.68
DiDi Global (DIDIY) China $17.303B 0.00
Avantor (AVTR) United States $14.163B 20.85
CochLear (CHEOY) Australia $14.103B 0.00
Viatris (VTRS) United States $14.098B 4.21
Revvity (RVTY) United States $13.345B 23.41
Medpace Holdings (MEDP) United States $13.053B 42.95
Natera (NTRA) United States $13.015B 0.00
Charles River Laboratories (CRL) United States $11.242B 21.52
Solventum (SOLV) United States $9.430B 0.00
Sonic Healthcare (SKHHY) Australia $8.373B 0.00
HealthEquity (HQY) United States $6.385B 40.99
Bausch + Lomb (BLCO) Canada $5.974B 23.92
Organon (OGN) United States $5.395B 5.12
Doximity (DOCS) United States $5.233B 36.65
PACS (PACS) United States $4.921B 0.00
Life Times (LTH) United States $4.146B 43.44
Sotera Health (SHC) United States $3.705B 18.18
Surgery Partners (SGRY) United States $3.692B 33.78
GoodRx Holdings (GDRX) United States $3.189B 121.43
Agilon Health (AGL) United States $2.834B 0.00
Progyny (PGNY) United States $2.646B 45.56
AMN Healthcare Services Inc (AMN) United States $2.167B 8.59
Premier (PINC) United States $2.051B 8.78
BrightSpring Health Services (BTSG) United States $2.004B 0.00
Alignment Healthcare (ALHC) United States $1.925B 0.00
Teladoc Health (TDOC) United States $1.542B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.467B 0.00
Establishment Labs Holdings (ESTA) $1.251B 0.00
GeneDx Holdings (WGS) United States $0.831B 0.00
InnovAge Holding (INNV) United States $0.825B 0.00
Embecta (EMBC) United States $0.760B 5.16
Auna S.A (AUNA) Luxembourg $0.657B 0.00
Pediatrix Medical (MD) United States $0.633B 6.71
COMPASS Pathways (CMPS) United Kingdom $0.499B 0.00
Sharecare (SHCR) United States $0.497B 0.00
Enhabit (EHAB) United States $0.476B 47.45
Sonida Senior Living (SNDA) United States $0.407B 0.00
QDM (QDMI) Hong Kong, SAR China $0.353B 9.24
ModivCare (MODV) United States $0.335B 6.27
DocGo (DCGO) United States $0.314B 17.17
LifeMD (LFMD) United States $0.274B 0.00
MultiPlan (MPLN) United States $0.258B 0.00
Sera Prognostics (SERA) United States $0.255B 0.00
Beauty Health (SKIN) United States $0.221B 0.00
Biodesix (BDSX) United States $0.203B 0.00
Ascend Wellness Holdings (AAWH) United States $0.194B 0.00
So-Young (SY) China $0.100B 48.51
Pono Capital Two (PTWO) United States $0.068B 0.00
NeueHealth (NEUE) United States $0.043B 5.82
Co-Diagnostics (CODX) United States $0.041B 0.00
Oncology Institute (TOI) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.034B 0.00
Nutex Health (NUTX) United States $0.034B 0.00
OncoCyte (OCX) United States $0.027B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.024B 0.00
SeaStar Medical Holding (ICU) United States $0.024B 0.00
TRxADE HEALTH (MEDS) United States $0.021B 0.00
Singular Genomics Systems (OMIC) United States $0.020B 0.00
KindlyMD (KDLY) $0.017B 0.00
BIMI Holdings (BIMI) United States $0.016B 0.00
BioNexus Gene Lab (BGLC) $0.009B 0.00
XWELL (XWEL) United States $0.007B 0.00
Intelligent Bio Solutions (INBS) United States $0.005B 0.00
OpGen (OPGN) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Singapore $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Assure Holdings (IONM) United States $0.002B 0.00